Format

Send to

Choose Destination
See comment in PubMed Commons below
Bioorg Med Chem Lett. 2004 Dec 20;14(24):6045-8.

Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies.

Author information

  • 1Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, USA. daishi_su@merck.com

Abstract

We have developed an efficient and selective radioligand, the [35S]-radiolabeled dihydroquinoxalinone derivative, 4, for an ex vivo receptor occupancy assay in transgenic rats over-expressing the human bradykinin B1 receptor.

[PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Chemical Information

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk